Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Kinoshita M
First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Japan.
J Card Fail. 2001 Dec;7(4):322-8. doi: 10.1054/jcaf.2001.30134.
Cardiac natriuretic peptides may induce apoptosis in myocytes; however, the relationship between plasma levels of cardiac natriuretic peptides and those of soluble Fas (sFas) and tumor necrosis factor (TNF)-alpha remains unknown in patients with congestive heart failure (CHF).
We measured plasma levels of sFas and TNF-alpha and those of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), norepinephrine, and endothelin 1 in 96 patients with CHF (ejection fraction < 45%). The patients were monitored for 3 years. Plasma levels of sFas and TNF-alpha increased with the severity of CHF. There was no significant correlation between sFas plasma levels and those of ANP and BNP. Cox proportional hazard analysis showed that high levels of sFas (P = .009) and BNP (P < .0001) and a low ejection fraction (P = .019) were independent significant prognostic predictors.
There is no significant correlation between cardiac natriuretic peptide and sFas levels in plasma. Plasma sFas is a useful prognostic marker independent of neurohumoral factors, suggesting that immune activation and/or apoptosis play a significant role in the pathogenesis of CHF.
心脏利钠肽可能诱导心肌细胞凋亡;然而,在充血性心力衰竭(CHF)患者中,血浆心脏利钠肽水平与可溶性Fas(sFas)及肿瘤坏死因子(TNF)-α水平之间的关系尚不清楚。
我们测定了96例CHF患者(射血分数<45%)的血浆sFas、TNF-α、心房利钠肽(ANP)、脑利钠肽(BNP)、去甲肾上腺素和内皮素1水平。对患者进行了3年的监测。血浆sFas和TNF-α水平随CHF严重程度增加而升高。sFas血浆水平与ANP和BNP水平之间无显著相关性。Cox比例风险分析显示,高水平的sFas(P = .009)、BNP(P < .0001)和低射血分数(P = .019)是独立的显著预后预测指标。
血浆中心脏利钠肽与sFas水平之间无显著相关性。血浆sFas是一种独立于神经体液因素的有用预后标志物,提示免疫激活和/或凋亡在CHF发病机制中起重要作用。